OCBCO
PACB icon

Oversea-Chinese Banking Corp (OCBC)’s Pacific Biosciences PACB Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,497
Closed -$143K – 372
2022
Q4 		$143K Buy
+17,497
New +$151K 0.01% 335

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s PACB Position: Q1 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Pacific Biosciences (PACB) in Q1 2023, closing a stake of 17,497 shares — an estimated $143K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in PACB in Q4 2022 and held it in 1 quarter. The position peaked at $143K in Q4 2022. 259 funds tracked by Wall St. Rank hold PACB as of Q1 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Pacific Biosciences position as of Q1 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 17,497 Pacific Biosciences shares in Q1 2023, an estimated $143K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Pacific Biosciences in Q4 2022 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s Pacific Biosciences position peaked at $143K in Q4 2022.
  • 259 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2023, filed 4 May 2023.